APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacovigilance (PV) Outsourcing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmacovigilance (PV) Outsourcing Market Analysis and Forecast 2026-2032

20 December 2025217 pages

Choose your research edition.

Industry ResearchPharmacovigilance (PV) Outsourcing Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacovigilance (PV) Outsourcing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pharmacovigilance (PV) Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacovigilance (PV) Outsourcing Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacovigilance (PV) Outsourcing Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Pharmacovigilance (PV) Outsourcing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmacovigilance (PV) Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmacovigilance (PV) Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmacovigilance (PV) Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmacovigilance (PV) Outsourcing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmacovigilance (PV) Outsourcing include Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation and iMED Global Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmacovigilance (PV) Outsourcing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmacovigilance (PV) Outsourcing, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmacovigilance (PV) Outsourcing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmacovigilance (PV) Outsourcing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmacovigilance (PV) Outsourcing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmacovigilance (PV) Outsourcing revenue, projected growth trends, production technology, application and end-user industry.

Pharmacovigilance (PV) Outsourcing Segment by Company

Accenture

C3i Solutions

Clintec

Covance

Deloitte Touche Tohmatsu Limited

ELC Group

Ergomed

iGATE Corporation

iMED Global Corporation

IQVIA

MarksMan Healthcare

Medpace Holdings

Oracle Corporation

Parexel

PharmInvent

PrimeVigilance

Pure Drug Safety

Sciformix

SIRO Clinpharm

Symogen

Novartis

Pharmacovigilance (PV) Outsourcing Segment by Type

Contract Research Organizations (CROs)

Business Process Outsourcing (BPOs)

Pharmacovigilance (PV) Outsourcing Segment by Application

Premarketing Clinical Trial

Post-marketing Clinical Practice

Other

Pharmacovigilance (PV) Outsourcing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance (PV) Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance (PV) Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance (PV) Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmacovigilance (PV) Outsourcing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmacovigilance (PV) Outsourcing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacovigilance (PV) Outsourcing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Contract Research Organizations (CROs) Major Player Table 3. Business Process Outsourcing (BPOs) Major Player Table 4. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Premarketing Clinical Trial Major Player Table 6. Post-marketing Clinical Practice Major Player Table 7. Other Major Player Table 8. Pharmacovigilance (PV) Outsourcing Industry Trends Table 9. Pharmacovigilance (PV) Outsourcing Industry Drivers Table 10. Pharmacovigilance (PV) Outsourcing Industry Opportunities and Challenges Table 11. Pharmacovigilance (PV) Outsourcing Industry Restraints Table 12. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2021-2026) Table 15. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2027-2032) Table 17. Global Pharmacovigilance (PV) Outsourcing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2021-2026) Table 19. Global Pharmacovigilance (PV) Outsourcing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharmacovigilance (PV) Outsourcing Key Players Headquarters & Area Served Table 21. Global Pharmacovigilance (PV) Outsourcing Players, Product Type & Application Table 22. Global Pharmacovigilance (PV) Outsourcing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharmacovigilance (PV) Outsourcing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Pharmacovigilance (PV) Outsourcing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2021-2026) Table 29. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2027-2032) Table 30. Global Pharmacovigilance (PV) Outsourcing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2021-2026) Table 34. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2027-2032) Table 35. Accenture Company Information Table 36. Accenture Business Overview Table 37. Accenture Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio Table 39. Accenture Recent Development Table 40. C3i Solutions Company Information Table 41. C3i Solutions Business Overview Table 42. C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio Table 44. C3i Solutions Recent Development Table 45. Clintec Company Information Table 46. Clintec Business Overview Table 47. Clintec Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio Table 49. Clintec Recent Development Table 50. Covance Company Information Table 51. Covance Business Overview Table 52. Covance Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Covance Pharmacovigilance (PV) Outsourcing Product Portfolio Table 54. Covance Recent Development Table 55. Deloitte Touche Tohmatsu Limited Company Information Table 56. Deloitte Touche Tohmatsu Limited Business Overview Table 57. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio Table 59. Deloitte Touche Tohmatsu Limited Recent Development Table 60. ELC Group Company Information Table 61. ELC Group Business Overview Table 62. ELC Group Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio Table 64. ELC Group Recent Development Table 65. Ergomed Company Information Table 66. Ergomed Business Overview Table 67. Ergomed Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio Table 69. Ergomed Recent Development Table 70. iGATE Corporation Company Information Table 71. iGATE Corporation Business Overview Table 72. iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 74. iGATE Corporation Recent Development Table 75. iMED Global Corporation Company Information Table 76. iMED Global Corporation Business Overview Table 77. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 79. iMED Global Corporation Recent Development Table 80. IQVIA Company Information Table 81. IQVIA Business Overview Table 82. IQVIA Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio Table 84. IQVIA Recent Development Table 85. MarksMan Healthcare Company Information Table 86. MarksMan Healthcare Business Overview Table 87. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio Table 89. MarksMan Healthcare Recent Development Table 90. Medpace Holdings Company Information Table 91. Medpace Holdings Business Overview Table 92. Medpace Holdings Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio Table 94. Medpace Holdings Recent Development Table 95. Oracle Corporation Company Information Table 96. Oracle Corporation Business Overview Table 97. Oracle Corporation Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 99. Oracle Corporation Recent Development Table 100. Parexel Company Information Table 101. Parexel Business Overview Table 102. Parexel Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio Table 104. Parexel Recent Development Table 105. PharmInvent Company Information Table 106. PharmInvent Business Overview Table 107. PharmInvent Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio Table 109. PharmInvent Recent Development Table 110. PrimeVigilance Company Information Table 111. PrimeVigilance Business Overview Table 112. PrimeVigilance Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio Table 114. PrimeVigilance Recent Development Table 115. Pure Drug Safety Company Information Table 116. Pure Drug Safety Business Overview Table 117. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio Table 119. Pure Drug Safety Recent Development Table 120. Sciformix Company Information Table 121. Sciformix Business Overview Table 122. Sciformix Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio Table 124. Sciformix Recent Development Table 125. SIRO Clinpharm Company Information Table 126. SIRO Clinpharm Business Overview Table 127. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio Table 129. SIRO Clinpharm Recent Development Table 130. Symogen Company Information Table 131. Symogen Business Overview Table 132. Symogen Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio Table 134. Symogen Recent Development Table 135. Novartis Company Information Table 136. Novartis Business Overview Table 137. Novartis Pharmacovigilance (PV) Outsourcing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio Table 139. Novartis Recent Development Table 140. North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 141. North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 142. North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 143. North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 144. North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Pharmacovigilance (PV) Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 147. Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 148. Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 149. Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 150. Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 151. Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 153. Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 154. China Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 155. China Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 156. China Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 157. China Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 161. Asia Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 162. Asia Pharmacovigilance (PV) Outsourcing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Pharmacovigilance (PV) Outsourcing Revenue by Region (US$ Million) & (2021-2026) Table 164. Asia Pharmacovigilance (PV) Outsourcing Revenue by Region (US$ Million) & (2027-2032) Table 165. SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 171. SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Pharmacovigilance (PV) Outsourcing Image Figure 2. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacovigilance (PV) Outsourcing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Contract Research Organizations (CROs) Image Figure 5. Business Process Outsourcing (BPOs) Image Figure 6. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pharmacovigilance (PV) Outsourcing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Premarketing Clinical Trial Image Figure 9. Post-marketing Clinical Practice Image Figure 10. Other Image Figure 11. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million) & (2021-2032) Figure 12. Global Pharmacovigilance (PV) Outsourcing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pharmacovigilance (PV) Outsourcing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Pharmacovigilance (PV) Outsourcing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Pharmacovigilance (PV) Outsourcing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2021-2032) Figure 19. Global Pharmacovigilance (PV) Outsourcing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2021-2032) Figure 22. North America Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2021-2032) Figure 24. North America Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2021-2032) Figure 25. North America Pharmacovigilance (PV) Outsourcing Revenue Share by Country (2021-2032) Figure 26. United States Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2021-2032) Figure 31. Europe Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2021-2032) Figure 32. Europe Pharmacovigilance (PV) Outsourcing Revenue Share by Country (2021-2032) Figure 33. Germany Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2021-2032) Figure 43. China Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2021-2032) Figure 44. Asia Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2021-2032) Figure 46. Asia Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2021-2032) Figure 47. Asia Pharmacovigilance (PV) Outsourcing Revenue Share by Region (2021-2032) Figure 48. Japan Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2021-2032) Figure 56. SAMEA Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2021-2032) Figure 57. SAMEA Pharmacovigilance (PV) Outsourcing Revenue Share by Country (2021-2032) Figure 58. Brazil Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Pharmacovigilance (PV) Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Contract Research Organizations (CROs)
  • Business Process Outsourcing (BPOs)
Applications
  • Premarketing Clinical Trial
  • Post-marketing Clinical Practice
  • Other
Companies covered
  • Accenture
  • C3i Solutions
  • Clintec
  • Covance
  • Deloitte Touche Tohmatsu Limited
  • ELC Group
  • Ergomed
  • iGATE Corporation
  • iMED Global Corporation
  • IQVIA
  • MarksMan Healthcare
  • Medpace Holdings
  • Oracle Corporation
  • Parexel
  • PharmInvent
  • PrimeVigilance
  • Pure Drug Safety
  • Sciformix
  • SIRO Clinpharm
  • Symogen
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmacovigilance (PV) Outsourcing Market by Type
  3. 1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Contract Research Organizations (CROs)
  5. 1.2.3 Business Process Outsourcing (BPOs)
  6. 1.3 Pharmacovigilance (PV) Outsourcing Market by Application
  7. 1.3.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Premarketing Clinical Trial
  9. 1.3.3 Post-marketing Clinical Practice
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pharmacovigilance (PV) Outsourcing Market Dynamics
  1. 2.1 Pharmacovigilance (PV) Outsourcing Industry Trends
  2. 2.2 Pharmacovigilance (PV) Outsourcing Industry Drivers
  3. 2.3 Pharmacovigilance (PV) Outsourcing Industry Opportunities and Challenges
  4. 2.4 Pharmacovigilance (PV) Outsourcing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmacovigilance (PV) Outsourcing Market Perspective (2021-2032)
  2. 3.2 Global Pharmacovigilance (PV) Outsourcing Growth Trends by Region
  3. 3.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmacovigilance (PV) Outsourcing Revenue by Players
  2. 4.1.1 Global Pharmacovigilance (PV) Outsourcing Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmacovigilance (PV) Outsourcing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmacovigilance (PV) Outsourcing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmacovigilance (PV) Outsourcing Key Players Headquarters & Area Served
  7. 4.4 Global Pharmacovigilance (PV) Outsourcing Players, Product Type & Application
  8. 4.5 Global Pharmacovigilance (PV) Outsourcing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmacovigilance (PV) Outsourcing Market CR5 and HHI
  11. 4.6.3 2025 Pharmacovigilance (PV) Outsourcing Tier 1, Tier 2, and Tier 3
5 Pharmacovigilance (PV) Outsourcing Market Size by Type
  1. 5.1 Global Pharmacovigilance (PV) Outsourcing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2032)
  3. 5.3 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2021-2032)
6 Pharmacovigilance (PV) Outsourcing Market Size by Application
  1. 6.1 Global Pharmacovigilance (PV) Outsourcing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2032)
  3. 6.3 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Accenture
  2. 7.1.1 Accenture Company Information
  3. 7.1.2 Accenture Business Overview
  4. 7.1.3 Accenture Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio
  6. 7.1.5 Accenture Recent Developments
  7. 7.2 C3i Solutions
  8. 7.2.1 C3i Solutions Company Information
  9. 7.2.2 C3i Solutions Business Overview
  10. 7.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio
  12. 7.2.5 C3i Solutions Recent Developments
  13. 7.3 Clintec
  14. 7.3.1 Clintec Company Information
  15. 7.3.2 Clintec Business Overview
  16. 7.3.3 Clintec Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio
  18. 7.3.5 Clintec Recent Developments
  19. 7.4 Covance
  20. 7.4.1 Covance Company Information
  21. 7.4.2 Covance Business Overview
  22. 7.4.3 Covance Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Covance Pharmacovigilance (PV) Outsourcing Product Portfolio
  24. 7.4.5 Covance Recent Developments
  25. 7.5 Deloitte Touche Tohmatsu Limited
  26. 7.5.1 Deloitte Touche Tohmatsu Limited Company Information
  27. 7.5.2 Deloitte Touche Tohmatsu Limited Business Overview
  28. 7.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio
  30. 7.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
  31. 7.6 ELC Group
  32. 7.6.1 ELC Group Company Information
  33. 7.6.2 ELC Group Business Overview
  34. 7.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio
  36. 7.6.5 ELC Group Recent Developments
  37. 7.7 Ergomed
  38. 7.7.1 Ergomed Company Information
  39. 7.7.2 Ergomed Business Overview
  40. 7.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio
  42. 7.7.5 Ergomed Recent Developments
  43. 7.8 iGATE Corporation
  44. 7.8.1 iGATE Corporation Company Information
  45. 7.8.2 iGATE Corporation Business Overview
  46. 7.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  48. 7.8.5 iGATE Corporation Recent Developments
  49. 7.9 iMED Global Corporation
  50. 7.9.1 iMED Global Corporation Company Information
  51. 7.9.2 iMED Global Corporation Business Overview
  52. 7.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  54. 7.9.5 iMED Global Corporation Recent Developments
  55. 7.10 IQVIA
  56. 7.10.1 IQVIA Company Information
  57. 7.10.2 IQVIA Business Overview
  58. 7.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio
  60. 7.10.5 IQVIA Recent Developments
  61. 7.11 MarksMan Healthcare
  62. 7.11.1 MarksMan Healthcare Company Information
  63. 7.11.2 MarksMan Healthcare Business Overview
  64. 7.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio
  66. 7.11.5 MarksMan Healthcare Recent Developments
  67. 7.12 Medpace Holdings
  68. 7.12.1 Medpace Holdings Company Information
  69. 7.12.2 Medpace Holdings Business Overview
  70. 7.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio
  72. 7.12.5 Medpace Holdings Recent Developments
  73. 7.13 Oracle Corporation
  74. 7.13.1 Oracle Corporation Company Information
  75. 7.13.2 Oracle Corporation Business Overview
  76. 7.13.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  78. 7.13.5 Oracle Corporation Recent Developments
  79. 7.14 Parexel
  80. 7.14.1 Parexel Company Information
  81. 7.14.2 Parexel Business Overview
  82. 7.14.3 Parexel Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio
  84. 7.14.5 Parexel Recent Developments
  85. 7.15 PharmInvent
  86. 7.15.1 PharmInvent Company Information
  87. 7.15.2 PharmInvent Business Overview
  88. 7.15.3 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio
  90. 7.15.5 PharmInvent Recent Developments
  91. 7.16 PrimeVigilance
  92. 7.16.1 PrimeVigilance Company Information
  93. 7.16.2 PrimeVigilance Business Overview
  94. 7.16.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio
  96. 7.16.5 PrimeVigilance Recent Developments
  97. 7.17 Pure Drug Safety
  98. 7.17.1 Pure Drug Safety Company Information
  99. 7.17.2 Pure Drug Safety Business Overview
  100. 7.17.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio
  102. 7.17.5 Pure Drug Safety Recent Developments
  103. 7.18 Sciformix
  104. 7.18.1 Sciformix Company Information
  105. 7.18.2 Sciformix Business Overview
  106. 7.18.3 Sciformix Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio
  108. 7.18.5 Sciformix Recent Developments
  109. 7.19 SIRO Clinpharm
  110. 7.19.1 SIRO Clinpharm Company Information
  111. 7.19.2 SIRO Clinpharm Business Overview
  112. 7.19.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  113. 7.19.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio
  114. 7.19.5 SIRO Clinpharm Recent Developments
  115. 7.20 Symogen
  116. 7.20.1 Symogen Company Information
  117. 7.20.2 Symogen Business Overview
  118. 7.20.3 Symogen Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio
  120. 7.20.5 Symogen Recent Developments
  121. 7.21 Novartis
  122. 7.21.1 Novartis Company Information
  123. 7.21.2 Novartis Business Overview
  124. 7.21.3 Novartis Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio
  126. 7.21.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Pharmacovigilance (PV) Outsourcing Revenue (2021-2032)
  2. 8.2 North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032)
  5. 8.3 North America Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032)
  9. 8.5 North America Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmacovigilance (PV) Outsourcing Revenue by Country
  11. 8.6.1 North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Pharmacovigilance (PV) Outsourcing Revenue (2021-2032)
  2. 9.2 Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmacovigilance (PV) Outsourcing Revenue by Country
  11. 9.6.1 Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Pharmacovigilance (PV) Outsourcing Revenue (2021-2032)
  2. 10.2 China Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032)
  5. 10.3 China Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032)
  9. 10.5 China Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmacovigilance (PV) Outsourcing Revenue (2021-2032)
  2. 11.2 Asia Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmacovigilance (PV) Outsourcing Revenue by Country
  11. 11.6.1 Asia Pharmacovigilance (PV) Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmacovigilance (PV) Outsourcing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmacovigilance (PV) Outsourcing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmacovigilance (PV) Outsourcing Revenue (2021-2032)
  2. 12.2 SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Country
  11. 12.6.1 SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmacovigilance (PV) Outsourcing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst